Google+ Facebook Twitter Twitter

Point-of-care testing

Point of Care Project Manager Rakhee Surti outlines a unique project to enhance patient health outcomes in the community.

est Blood Glucose For Diabetes stock photo-CREDIT-istock-836372378

In June 2022, I was appointed as a Project Manager to lead on a discovery project for point-of-care testing (POCT). My role was to work on a vision that we had at Milton Keynes University Hospital (MKUH) based on the Pathology – Getting it Right First Time (GIRFT) report. This vision was to identify and discover POCT devices in use within our primary care service, namely GP practices, in order to look at the governance of POCT.

Click here to read the full article.

Image credit | iStock | Alamy

Related Articles

Medical Science Laboratory with Diverse Multi-Ethnic Team of Microbiology Scientists Have Meeting on Developing Drugs, Medicine, Doing Biotechnology Research-CREDIT_istock-1293772951

Equity, diversity and inclusion for all

Jemma Shead, a Senior Biomedical Scientist at Synnovis and IBMS EDI Working Group member, on how and why you should get involved with EDI.

adeno associated virus capsid-Image Credit | Science Photo Library - c0142837

Examining the medical mystery of child hepatitis outbreak

A study has shed light on an unexpected wave of severe acute hepatitis cases in 2022, amid the backdrop of the ongoing global COVID-19 pandemic.

clostridioides difficile bacteria-Image Credit | Science Photo Library - c0016337

Faecal microbiota transplant for C. diff

In the first comprehensive US evidence-based guideline on the use of faecal microbiota-based therapies for gastrointestinal disease, the American Gastroenterological Association recommends faecal microbiota transplant (FMT) for most patients with recurrent Clostridioides difficile (C. diff) infection.

pseudomonas aeruginosa bacteria Image-Credit | Science Photo Library - f0381226

Tackling priority pathogen with phages

A new study describes the use of phage therapy to eradicate multidrug-resistant Pseudomonas aeruginosa infections in vivo with important new implications for antibiotic resistance.